Literature DB >> 31276857

Combinatorial regulation of alternative splicing.

Hossein Shenasa1, Klemens J Hertel2.   

Abstract

The generation of protein coding mRNAs from pre-mRNA is a fundamental biological process that is required for gene expression. Alternative pre-mRNA splicing is responsible for much of the transcriptomic and proteomic diversity observed in higher order eukaryotes. Aberrations that disrupt regular alternative splicing patterns are known to cause human diseases, including various cancers. Alternative splicing is a combinatorial process, meaning many factors affect which two splice sites are ligated together. The features that dictate exon inclusion are comprised of splice site strength, intron-exon architecture, RNA secondary structure, splicing regulatory elements, promoter use and transcription speed by RNA polymerase and the presence of post-transcriptional nucleotide modifications. A comprehensive view of all of the factors that influence alternative splicing decisions is necessary to predict splicing outcomes and to understand the molecular basis of disease. This article is part of a Special Issue entitled: RNA structure and splicing regulation edited by Francisco Baralle, Ravindra Singh and Stefan Stamm.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Alternative splicing; Exon architecture; RNA modification; RNA secondary structure; Splice site strength; Splicing regulators

Mesh:

Substances:

Year:  2019        PMID: 31276857     DOI: 10.1016/j.bbagrm.2019.06.003

Source DB:  PubMed          Journal:  Biochim Biophys Acta Gene Regul Mech        ISSN: 1874-9399            Impact factor:   4.490


  16 in total

1.  Exon Definition Facilitates Reliable Control of Alternative Splicing in the RON Proto-Oncogene.

Authors:  Mihaela Enculescu; Simon Braun; Samarth Thonta Setty; Anke Busch; Kathi Zarnack; Julian König; Stefan Legewie
Journal:  Biophys J       Date:  2020-03-03       Impact factor: 4.033

2.  RNA structure and splicing regulation.

Authors:  Francisco E Baralle; Ravindra N Singh; Stefan Stamm
Journal:  Biochim Biophys Acta Gene Regul Mech       Date:  2019-11-12       Impact factor: 4.490

Review 3.  The physiology of alternative splicing.

Authors:  Luciano E Marasco; Alberto R Kornblihtt
Journal:  Nat Rev Mol Cell Biol       Date:  2022-10-13       Impact factor: 113.915

Review 4.  Structural Context of a Critical Exon of Spinal Muscular Atrophy Gene.

Authors:  Natalia N Singh; Collin A O'Leary; Taylor Eich; Walter N Moss; Ravindra N Singh
Journal:  Front Mol Biosci       Date:  2022-07-01

5.  Splice site proximity influences alternative exon definition.

Authors:  Francisco Carranza; Hossein Shenasa; Klemens J Hertel
Journal:  RNA Biol       Date:  2022-01       Impact factor: 4.766

Review 6.  RNA in spinal muscular atrophy: therapeutic implications of targeting.

Authors:  Ravindra N Singh; Joonbae Seo; Natalia N Singh
Journal:  Expert Opin Ther Targets       Date:  2020-06-25       Impact factor: 6.902

Review 7.  Splicing regulation in brain and testis: common themes for highly specialized organs.

Authors:  Chiara Naro; Eleonora Cesari; Claudio Sette
Journal:  Cell Cycle       Date:  2021-02-26       Impact factor: 4.534

Review 8.  Intrinsic Regulatory Role of RNA Structural Arrangement in Alternative Splicing Control.

Authors:  Katarzyna Taylor; Krzysztof Sobczak
Journal:  Int J Mol Sci       Date:  2020-07-21       Impact factor: 5.923

Review 9.  The Emerging Role of the RBM20 and PTBP1 Ribonucleoproteins in Heart Development and Cardiovascular Diseases.

Authors:  Stefania Fochi; Pamela Lorenzi; Marilisa Galasso; Chiara Stefani; Elisabetta Trabetti; Donato Zipeto; Maria Grazia Romanelli
Journal:  Genes (Basel)       Date:  2020-04-08       Impact factor: 4.096

Review 10.  Hypoxia-induced alternative splicing: the 11th Hallmark of Cancer.

Authors:  Antonietta Rosella Farina; Lucia Cappabianca; Michela Sebastiano; Veronica Zelli; Stefano Guadagni; Andrew Reay Mackay
Journal:  J Exp Clin Cancer Res       Date:  2020-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.